Docoh
Loading...

XTLB X.T.L. Biopharmaceuticals

XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.

XTLB stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

15 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

9.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 5 5
Opened positions 1 1
Closed positions 1 0 NEW
Increased positions 1 1
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 1.44M 848K +69.5%
Total shares 474.13K 446.24K +6.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Noked Capital 198.89K $603K 0.0%
Noked Israel 198.89K $603K 0.0%
MS Morgan Stanley 56.82K $172K +19.8%
Renaissance Technologies 19.53K $59K NEW
Proequities 0 $0
Largest transactions
Shares Bought/sold Change
Renaissance Technologies 19.53K +19.53K NEW
MS Morgan Stanley 56.82K +9.39K +19.8%
UBS UBS Group AG - Registered Shares 0 -1.04K EXIT
Proequities 0 0
Noked Capital 198.89K 0 0.0%
Noked Israel 198.89K 0 0.0%

Financial report summary

?
Competition
AMGENImmunomedicsCelgeneBiogenRocheNovartisMerck SeronoGlaxosmithklineUcb
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AER, ago, Aurinia, Avivim, CER, coupon, dysfunction, Editorial, enlarge, Geneva, HIVDB, Lecturer, lessee, Liverpool, macroeconomic, Mei, membership, Menachem, OTHE, postulated, protein, regimen, Road, sharp, Subcommittee, Turgemman, unrecognized, unvested, USD, Voclosporin
Removed: accountable, Adjunct, aforesaid, ancillary, announced, article, Assistant, Belgium, Bezeq, Budget, cancer, Clalit, closing, compensate, defect, departure, determinable, division, Efficiency, emerge, EPO, focusing, forfeited, Gibraltar, Gold, Hamered, HCW, hispro, Holim, IGLD, improvement, incurable, inInternal, investigation, knowledgeable, Kupat, largest, main, malignant, Micronet, minocycline, Nagar, negotiating, Oded, opening, ourADSscould, outline, Parliament, people, plasma, pool, prolongation, psychotic, regression, reversed, Revised, Shalevjoined, SPA, Steering, survival, Tower, Turgemanjoined, unissued, unregistered

Proxies

No filings